Showing results (441-450 of 711) with videos related to

Sort By:
Pageof 72
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2020
Clinical Outcomes of Coronavirus Disease 2019 With Evidence-based Supportive CareDerek T Larson, John H Sherner, Kia M Gallagher, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|June 1, 1996
Early tracheostomy in trauma patientsY Kluger, D B Paul, J Lucke, et al.
Seizure|June 2, 2018
Complement system biomarkers in epilepsyMaja Kopczynska, Wioleta M Zelek, Simone Vespa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease riskMeike Heurich, Ruben Martínez-Barricarte, Nigel J Francis, et al.
The Journal of Biological Chemistry|January 30, 2015
Forkhead box F2 regulation of platelet-derived growth factor and myocardin/serum response factor signaling is essential for intestinal developmentCraig Bolte, Xiaomeng Ren, Tatiana Tomley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?Baalasubramanian Sivasankar, M Paula Longhi, Kathleen M E Gallagher, et al.
Journal of Neuroimmunology|July 31, 2008
The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barré syndromeHugh J Willison, Susan K Halstead, Erin Beveridge, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2016
The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's DiseaseAngharad R Morgan, Samuel Touchard, Caroline O'Hagan, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 27, 2003
Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modificationSusana B Read, Nisha V Kulprathipanja, German G Gomez, et al.
Pageof 72